Table: Wakamoto Pharm -2019/20 parent results

Wakamoto Pharmaceutical

27/05/2020 07:00

May 27 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           10.92           10.74          10.10                 
               (+1.6 pct)      (-1.5 pct)     (-7.5 pct)               
  Operating   loss 996 mln    loss 391 mln      10 mln                 
  Recurring   loss 911 mln    loss 409 mln      40 mln                 
  Net           loss 1.66     loss 181 mln      240 mln                
  EPS        loss 47.73 yen   loss 5.22 yen    6.91 yen                
  Ann Div          NIL             NIL                                 
  -Q2 Div          NIL             NIL                                 
  -Q4 Div          NIL             NIL                                 
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T